1. Home
  2. RWT vs PHVS Comparison

RWT vs PHVS Comparison

Compare RWT & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

N/A

Current Price

$5.71

Market Cap

707.5M

Sector

Real Estate

ML Signal

N/A

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

N/A

Current Price

$28.33

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RWT
PHVS
Founded
1994
2015
Country
United States
Switzerland
Employees
351
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
707.5M
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RWT
PHVS
Price
$5.71
$28.33
Analyst Decision
Buy
Buy
Analyst Count
8
10
Target Price
$6.91
$40.60
AVG Volume (30 Days)
1.4M
186.7K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
12.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.59
N/A
Revenue Next Year
$22.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.68
$11.51
52 Week High
$6.97
$29.85

Technical Indicators

Market Signals
Indicator
RWT
PHVS
Relative Strength Index (RSI) 50.00 58.97
Support Level $5.39 $24.55
Resistance Level $5.90 $29.80
Average True Range (ATR) 0.17 1.22
MACD 0.03 0.27
Stochastic Oscillator 66.88 74.69

Price Performance

Historical Comparison
RWT
PHVS

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: